{{Rsnum
|rsid=2675163
|Gene=SLC6A1
|Chromosome=3
|position=11033328
|Orientation=plus
|GMAF=0.2314
|Gene_s=SLC6A1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.5 | 38.9 | 57.5
| HCB | 11.7 | 48.9 | 39.4
| JPT | 15.9 | 41.6 | 42.5
| YRI | 0.0 | 17.0 | 83.0
| ASW | 0.0 | 21.1 | 78.9
| CHB | 11.7 | 48.9 | 39.4
| CHD | 17.4 | 39.4 | 43.1
| GIH | 5.9 | 38.6 | 55.4
| LWK | 0.0 | 14.5 | 85.5
| MEX | 6.9 | 37.9 | 55.2
| MKK | 0.6 | 9.6 | 89.7
| TSI | 4.9 | 45.1 | 50.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22437554
|Trait=None
|Title=Genome-wide association study identifies three common variants associated with serologic response to vitamin E supplementation in men.
|RiskAllele=C
|Pval=0.000006
|OR=0.6800
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}